Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Peanuts May Improve Arterial Health, Reduce the Risk of Cardiovascular Disease



The researchers found that consuming peanuts helped to lessen the release of lipids into the bloodstream. 

Share this!

April 3, 2017 | by Sarah Hand, M.Sc.

According to researchers at The Pennsylvania State University, peanut consumption at mealtime could help reduce the risk of heart attacks, strokes and other cardiovascular diseases. The researchers published their findings in The Journal of Nutrition.

“Typically, whenever we eat something, it causes the arteries to get a little bit stiffer during the post-meal period, but we have shown that if you eat peanuts with your meal, this can help prevent the stiffening response,” said Penny Kris-Etherton, distinguished professor of nutrition, Penn State. “When the stiffening response happens in the cells that line the arteries, resulting in decreased elasticity in the arteries, it can limit the availability of nitric oxide, and when there's less nitric oxide, the arteries don't dilate that much. What you want is a dilation of the arteries and for them to be really elastic.”

During the study, the researchers gave overweight and obese men approximately three ounces of peanuts to eat along with a high-fat meal. The researchers found that consuming peanuts helped to lessen the release of lipids into the bloodstream.

This spike in blood lipid concentration after consuming a fatty meal has previously been associated with a higher risk of cardiovascular disease. As postprandial arterial stiffening can force the heart muscle to pump harder to pump the blood through the vessels, this phenomenon can also increase the risk of cardiovascular events.

“As the heart works harder and harder, over a long period of time, it could lead, ultimately, to heart failure,” said Kris-Etherton. According to the researchers, peanuts could help the arterial cells retain their elasticity, potentially minimizing the risk of heart attacks and strokes.

“After a meal, triglycerides increase and this typically decreases the dilation of the arteries, but the peanuts prevent that big increase in triglycerides after the meal,” said Kris-Etherton. “And that may be the mechanism behind this effect, because the triglycerides are not getting so high, which may explain why there is not a decrease in artery elasticity.”

Kris-Etherton and her colleagues observed a 32 percent reduction in blood triglyceride levels after the high-fat meals were consumed with peanuts, compared to a control group. The researchers plan to conduct larger studies in the future, involving both men and women, in order to study the potential health benefits of peanuts.

Keywords:  Cardiovascular Disease, Heart Attack, Stroke


Share this with your colleagues!

Canadian Regulator Recalls Pie Shells Over E. Coli Contaminated Flour

April 28, 2017 - Multiple brands of pie and tart shells are being recalled in Canada after the flour used to manufacture them was linked to 28 cases of illness due to infection with E. coli O121.

Featured In: Food News

FDA Sends Warning Letters to Manufacturers of Fake Cancer Drugs

April 27, 2017 - The FDA is cracking down on the sale of illegal cancer drugs by sending warning letters to 14 US companies selling the unapproved products.

Featured In: Life Science News, Drug Safety News

Womb-Like Device Could Increase Survival of Premature Babies

April 27, 2017 - Researchers at the Children's Hospital of Philadelphia (CHOP) have developed a womb-like device which mimics the environmental conditions found inside the uterus.

Featured In: Life Science News, Medical Device News


What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation


Technology Solutions for Late Phase Research: Optimising Real World Data Assets

Serialization for Late Starters – With Live Industry Research Results

Clinical Not All Antioxidants Are Created Equal: Astaxanthin, The Antioxidant Powerhouse

The New Gold Standards of IRT Delivery for Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.